BRCA1 Mutations in Southern England
Author Information
Author(s): DM Eccles, P Englefield, MA Soulby, IG Campbell
Primary Institution: Princess Ann Hospital, Southampton, UK
Hypothesis
Can a cost-effective approach to BRCA1 mutation analysis be established for women with breast cancer in southern England?
Conclusion
A targeted approach to BRCA1 mutation analysis can effectively identify mutations in women with a strong family history of breast or ovarian cancer at a lower cost.
Supporting Evidence
- 6.5% of women diagnosed with breast cancer under 40 had detectable BRCA1 mutations.
- 26.7% of women with a strong family history of breast or ovarian cancer had detectable mutations.
- The cost of screening a carefully selected patient cohort is significantly lower than screening the entire population.
Takeaway
The study looked at women with breast cancer to see if they had certain gene mutations that could increase their cancer risk, and found that testing only those with a strong family history is cheaper and more effective.
Methodology
The study screened 230 women with breast cancer for BRCA1 mutations, categorizing them based on age of diagnosis and family history.
Limitations
The study did not detect mutations in all groups, particularly in bilateral breast cancer cases.
Participant Demographics
Women diagnosed with breast cancer from the Wessex region of southern England.
Want to read the original?
Access the complete publication on the publisher's website